List of Heptares Therapeutics patents

Patents where

Current Assignee

Name

‌

Heptares Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10112923 1,2,4-triazine-4-amine derivatives	Patent 10112923 was granted and assigned to Heptares Therapeutics on October, 2018 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	10112923	October 30, 2018
‌ US Patent 9249130 1,2,4-triazine-4-amine derivatives	Patent 9249130 was granted and assigned to Heptares Therapeutics on February, 2016 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	9249130	February 2, 2016
‌ US Patent 10988455 1,2,4-triazine-4-amine derivatives	Patent 10988455 was granted and assigned to Heptares Therapeutics on April, 2021 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	10988455	April 27, 2021
‌ US Patent 8703915 Mutant proteins and methods for producing them	Patent 8703915 was granted and assigned to Heptares Therapeutics on April, 2014 by the United States Patent and Trademark Office.		‌ Heptares Therapeutics	United States Patent and Trademark Office	8703915	April 22, 2014
‌ US Patent 9260505 Methods for screening for binding partners of G-protein coupled receptors	Patent 9260505 was granted and assigned to Heptares Therapeutics on February, 2016 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	9260505	February 16, 2016
‌ US Patent 11773090 Pharmaceutical compounds	Patent 11773090 was granted and assigned to Heptares Therapeutics on October, 2023 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	11773090	October 3, 2023
‌ US Patent 11834407 Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists	Patent 11834407 was granted and assigned to Heptares Therapeutics on December, 2023 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	11834407	December 5, 2023
‌ US Patent 10196380 Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists	Patent 10196380 was granted and assigned to Heptares Therapeutics on February, 2019 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	10196380	February 5, 2019
‌ US Patent 10385039 Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists	Patent 10385039 was granted and assigned to Heptares Therapeutics on August, 2019 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	10385039	August 20, 2019
‌ US Patent 10961225 Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor	Patent 10961225 was granted and assigned to Heptares Therapeutics on March, 2021 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	10961225	March 30, 2021
‌ US Patent 11324738 Muscarinic agonists	Patent 11324738 was granted and assigned to Heptares Therapeutics on May, 2022 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	11324738	May 10, 2022
‌ US Patent 9670183 Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists	Patent 9670183 was granted and assigned to Heptares Therapeutics on June, 2017 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	9670183	June 6, 2017
‌ US Patent 9926297 Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists	Patent 9926297 was granted and assigned to Heptares Therapeutics on March, 2018 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	9926297	March 27, 2018
‌ US Patent 11339383 G proteins	Patent 11339383 was granted and assigned to Heptares Therapeutics on May, 2022 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	11339383	May 24, 2022
‌ US Patent 9593106 Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists	Patent 9593106 was granted and assigned to Heptares Therapeutics on March, 2017 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	9593106	March 14, 2017
‌ US Patent 10973832 Muscarinic M1 receptor agonists	Patent 10973832 was granted and assigned to Heptares Therapeutics on April, 2021 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	10973832	April 13, 2021
‌ US Patent 10030012 Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists	Patent 10030012 was granted and assigned to Heptares Therapeutics on July, 2018 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	10030012	July 24, 2018
‌ US Patent 10030035 Muscarinic receptor agonists	Patent 10030035 was granted and assigned to Heptares Therapeutics on July, 2018 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	10030035	July 24, 2018
‌ US Patent 9573929 Muscarinic M1 receptor agonists	Patent 9573929 was granted and assigned to Heptares Therapeutics on February, 2017 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	9573929	February 21, 2017
‌ US Patent 9266857 Bicyclic AZA compounds as muscarinic M1 receptor agonists	Patent 9266857 was granted and assigned to Heptares Therapeutics on February, 2016 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	9266857	February 23, 2016
‌ US Patent 10995072 Inhibitors of protease-activated receptor-2	Patent 10995072 was granted and assigned to Heptares Therapeutics on May, 2021 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	10995072	May 4, 2021
‌ US Patent 10259787 Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists	Patent 10259787 was granted and assigned to Heptares Therapeutics on April, 2019 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	10259787	April 16, 2019
‌ US Patent 9907805 Muscarinic M1 receptor agonists	Patent 9907805 was granted and assigned to Heptares Therapeutics on March, 2018 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	9907805	March 6, 2018
‌ US Patent 9975890 Bicyclic AZA compounds as muscarinic M1 receptor antagonists	Patent 9975890 was granted and assigned to Heptares Therapeutics on May, 2018 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	9975890	May 22, 2018
‌ US Patent 10259802 Bicyclic aza compounds as muscarinic M1 receptor antagonists	Patent 10259802 was granted and assigned to Heptares Therapeutics on April, 2019 by the United States Patent and Trademark Office.	‌ Heptares Therapeutics	‌ Heptares Therapeutics	United States Patent and Trademark Office	10259802	April 16, 2019

Results per page:

80 results

0 selected

80 results

0 selected